ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in ...
GOLETA, Calif. - Medical technology company Inogen, Inc. (NASDAQ:INGN) announced Wednesday the launch of its new Aurora CPAP masks, marking the company’s entry into the sleep apnea market. The company ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of ...
Investing.com -- Inogen Inc (NASDAQ:INGN) stock gained 5.7% on Wednesday after the medical technology company announced the launch of its Aurora CPAP masks, expanding its product portfolio into the ...
Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...
ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...
REMSleep Holdings has announced that it has received HCPCS approval from the Pricing, Data Analysis and Coding (PDAC) contractor for its DeltaWave nasal pillow system.
It was once feared weight-loss drugs would crush demand for sleep apnoea products. ResMed's December quarter has shown very ...
Sleep apnea is a serious condition, causing breathing to stop and start several times during sleep. The most common form of the condition is obstructive sleep apnea, where the throat narrows, blocking ...
Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share ...
Resmed Inc () has held its Q2 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools ...
Stockhead on MSN
Biocurious: What to expect in a ‘difficult’ profit-reporting season for healthcare stocks
Amid trashed valuations, investors await for signs of life for healthcare stocks in the February profit-reporting season. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results